A Study to Evaluate the Efficacy and Safety of Cabergoline Compared With Placebo for the Treatment of RLS

NCT00627003 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Restless Legs Syndrome

Interventions

DRUG: Cabergoline
OTHER: Placebo

Sponsor

Pfizer